Artwork

Content provided by MDedge and Medscape Professional Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MDedge and Medscape Professional Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Top dermatology resident takeovers of 2020

25:30
 
Share
 

Manage episode 271071609 series 2356616
Content provided by MDedge and Medscape Professional Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MDedge and Medscape Professional Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Episode 79, the top resident takeovers of 2020 (so far).

We count down the top downloaded resident interviews of Dermatology Weekly in 2020. So far this year, a variety of topics affecting residents have been covered—from the impact of training during COVID-19 to the use of low-dose naltrexone to over-the-counter (OTC) topicals in dermatology and Muir-Torre syndrome.

Dermatology residency during a pandemic, Episode 73: Dr. Candrice Heath talked to three dermatology residents—Dr. Brittany Oliver (on Instagram: @dr.dermatic), Dr. Sophie Greenberg (@sophiegreenberg), and Dr. Julie Croley (@DrSkinandSmiles)—about their experiences navigating through dermatology residency during the COVID-19 pandemic. They shared their perspectives from different areas of the country on how the current health crisis has impacted their training and responsibilities.

Low-dose naltrexone, Episode 52: Dr. Daniel Mazori talked to Dr. Nadine Shabeeb about the benefits of off-label low-dose naltrexone (LDN) for the treatment of inflammatory skin conditions. Dr. Shabeeb provided a practical perspective on prescribing LDN in the dermatology setting and discussed how to counsel patients about potential side effects, including concerns about its abuse potential.

OTC topicals, Episode 65: Dr. Daniel Mazori talked to Dr. Sophie Greenberg about selection of OTC topicals to avoid potential adverse effects. They discussed how the Food and Drug Administration categorizes and regulates OTC products as well as resources to learn more about common ingredients in OTC topicals.

Muir-Torre syndrome (MTS), Episode 61: Dr. Daniel Mazori talked to Dr. Mohammed Dany about the pathogenesis of MTS and its associated malignancies. They also reviewed diagnostic clues and tools for dermatologists when treating patients with solitary sebaceous tumors.

Host: Nick Andrews

Dr. Croley, Dr. Dany, Dr. Greenberg, Dr. Heath, Dr. Mazori, Dr. Oliver, and Dr. Shabeeb report no conflicts of interest.

Show notes by: Melissa Sears, Alicia Sonners

You can find more of our podcasts at http://www.mdedge.com/podcasts

Email the show: podcasts@mdedge.com

Interact with us on Twitter: @MDedgeDerm

  continue reading

106 episodes

Artwork
iconShare
 
Manage episode 271071609 series 2356616
Content provided by MDedge and Medscape Professional Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MDedge and Medscape Professional Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Episode 79, the top resident takeovers of 2020 (so far).

We count down the top downloaded resident interviews of Dermatology Weekly in 2020. So far this year, a variety of topics affecting residents have been covered—from the impact of training during COVID-19 to the use of low-dose naltrexone to over-the-counter (OTC) topicals in dermatology and Muir-Torre syndrome.

Dermatology residency during a pandemic, Episode 73: Dr. Candrice Heath talked to three dermatology residents—Dr. Brittany Oliver (on Instagram: @dr.dermatic), Dr. Sophie Greenberg (@sophiegreenberg), and Dr. Julie Croley (@DrSkinandSmiles)—about their experiences navigating through dermatology residency during the COVID-19 pandemic. They shared their perspectives from different areas of the country on how the current health crisis has impacted their training and responsibilities.

Low-dose naltrexone, Episode 52: Dr. Daniel Mazori talked to Dr. Nadine Shabeeb about the benefits of off-label low-dose naltrexone (LDN) for the treatment of inflammatory skin conditions. Dr. Shabeeb provided a practical perspective on prescribing LDN in the dermatology setting and discussed how to counsel patients about potential side effects, including concerns about its abuse potential.

OTC topicals, Episode 65: Dr. Daniel Mazori talked to Dr. Sophie Greenberg about selection of OTC topicals to avoid potential adverse effects. They discussed how the Food and Drug Administration categorizes and regulates OTC products as well as resources to learn more about common ingredients in OTC topicals.

Muir-Torre syndrome (MTS), Episode 61: Dr. Daniel Mazori talked to Dr. Mohammed Dany about the pathogenesis of MTS and its associated malignancies. They also reviewed diagnostic clues and tools for dermatologists when treating patients with solitary sebaceous tumors.

Host: Nick Andrews

Dr. Croley, Dr. Dany, Dr. Greenberg, Dr. Heath, Dr. Mazori, Dr. Oliver, and Dr. Shabeeb report no conflicts of interest.

Show notes by: Melissa Sears, Alicia Sonners

You can find more of our podcasts at http://www.mdedge.com/podcasts

Email the show: podcasts@mdedge.com

Interact with us on Twitter: @MDedgeDerm

  continue reading

106 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide